Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Ceftaroline fosamil acetic acid solvate monohydrate 668.4mg
equivalent to ceftaroline fosamil 600mg
|Dosage Form:||Powder for injection|
|New Zealand Sponsor:||Pfizer New Zealand Limited|
|Manufacturer:||ACS Dobfar SpA, Teramo, Italy|
Dated this 10th day of August 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).